mitoxantrone has been researched along with Mouth Neoplasms in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gefitinib is an orally active, selective epidermal growth factor receptor-tyrosine kinase inhibitor." | 1.35 | Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines. ( Amano, O; Chu, Q; Kanda, Y; Kunii, S; Sakagami, H; Wang, Q, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, Q | 1 |
| Amano, O | 1 |
| Kanda, Y | 1 |
| Kunii, S | 1 |
| Wang, Q | 1 |
| Sakagami, H | 1 |
1 other study available for mitoxantrone and Mouth Neoplasms
| Article | Year |
|---|---|
Tumor-specific cytotoxicity and type of cell death induced by gefitinib in oral squamous cell carcinoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascorbic Acid; Autophagy; Carcinoma, Squa | 2009 |